Do people think the STO aquiring 20% of ESG will have much of a impact on MPO (other then putting the spotlight on the sector?)CheersCorporal
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
